# Calyxo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/calyxo-2

- Industry: Medical Devices & Equipment
- Headquarters: Pleasanton, US
- Website: www.calyxoinc.com
- Total disclosed funding: $113M
- Latest round: Series F (Apr 1, 2026)
- Investors on record: 6

## About

Based in California, US, and founded in 2016 by Jee Shin, Calyxo, Inc. fka Kalera Medical, Inc. is a provider of surgical devices for the removal of kidney stone fragments. In April 2026, Calyxo raised USD 40 million in series F funding co-led by Janus Henderson and Ally Bridge Group, with participation from Avidity Partners Management, Questa Capital, and CRG. As of 2022, the company is led by its CEO and president Joe Catanese III, PhD.

The company is the manufacturer of a device that is used for the retrieval of kidney stones. The firm uses CVAC  technology to achieve surgically free-stone removal by the process of irrigation and aspiration. 

The company plans to use the April 2026 funding to expand its commercial infrastructure for the CVAC System, advance clinical and health-economic evidence through ongoing and future studies, and support continued innovation in kidney stone care.

## Funding rounds

- Series F, Apr 1, 2026, $40M — Janus Henderson, CRG, Ally Bridge Group, Questa Capital, Avidity Partners Management
- Series D, Oct 27, 2023, $50M — CRG, Questa Capital, Avidity Partners
- Series C, Jan 24, 2022, $23M — CRG, Questa Capital

## Investors

- CRG — Series C, Series D, Series F
- Questa Capital (https://capitalatlas.ai/funds/questa-capital) — Series C, Series D, Series F
- Avidity Partners — Series D
- Janus Henderson (https://capitalatlas.ai/funds/janus-henderson) — Series F
- Ally Bridge Group (https://capitalatlas.ai/funds/ally-bridge-group) — Series F
- Avidity Partners Management — Series F